4882 — Perseus Proteomics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapNeutral

Annual balance sheet for Perseus Proteomics, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	Yuho	Yuho	Yuho
Standards:	JAS	JAS	JAS	JAS	JAS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	482	1,069	3,215	2,445	1,541
Net Total Accounts Receivable
Net Total Receivables	37.3	30.7	45.4	51.4	83.8
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	538	1,109	3,291	2,515	1,651
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0	0	0	0	0
Net Intangible Assets
Other Long Term Assets
Total Assets	548	1,119	3,301	2,567	1,694
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	62	34.9	148	111	129
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	62	34.9	148	170	295
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	486	1,084	3,152	2,397	1,398
Total Liabilities & Shareholders' Equity	548	1,119	3,301	2,567	1,694
Total Common Shares Outstanding